172 related articles for article (PubMed ID: 38393536)
1. Comparative analysis of genes expression involved in type II toxin-antitoxin system in Staphylococcus aureus following persister cell formation.
Karimaei S; Aghamir SMK; Pourmand MR
Mol Biol Rep; 2024 Feb; 51(1):324. PubMed ID: 38393536
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic tolerance in biofilm persister cells of Staphylococcus aureus and expression of toxin-antitoxin system genes.
Karimaei S; Kazem Aghamir SM; Foroushani AR; Pourmand MR
Microb Pathog; 2021 Oct; 159():105126. PubMed ID: 34384900
[TBL] [Abstract][Full Text] [Related]
3. The expression of type II TA system genes following persister cell formation in Pseudomonas aeruginosa isolates in the exponential and stationary phases.
Golmoradi Zadeh R; Mirshekar M; Sadeghi Kalani B; Pourghader J; Barati M; Masjedian Jazi F
Arch Microbiol; 2022 Jul; 204(8):451. PubMed ID: 35781545
[TBL] [Abstract][Full Text] [Related]
4. Isolation of persister cells within the biofilm and relative gene expression analysis of type II toxin/antitoxin system in Pseudomonas aeruginosa isolates in exponential and stationary phases.
Zadeh RG; Kalani BS; Ari MM; Talebi M; Razavi S; Jazi FM
J Glob Antimicrob Resist; 2022 Mar; 28():30-37. PubMed ID: 34922056
[TBL] [Abstract][Full Text] [Related]
5. A novel type I toxin-antitoxin system modulates persister cell formation in Staphylococcus aureus.
Habib G; Zhu J; Sun B
Int J Med Microbiol; 2020 Feb; 310(2):151400. PubMed ID: 32001143
[TBL] [Abstract][Full Text] [Related]
6. The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection.
Ma D; Mandell JB; Donegan NP; Cheung AL; Ma W; Rothenberger S; Shanks RMQ; Richardson AR; Urish KL
mBio; 2019 Nov; 10(6):. PubMed ID: 31772059
[No Abstract] [Full Text] [Related]
7. Effect of mazEF, higBA and relBE toxin-antitoxin systems on antibiotic resistance in Pseudomonas aeruginosa and Staphylococcus isolates.
Coskun USS; Cicek AC; Kilinc C; Guckan R; Dagcioglu Y; Demir O; Sandalli C
Malawi Med J; 2018 Jun; 30(2):67-72. PubMed ID: 30627331
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease.
Conlon BP
Bioessays; 2014 Oct; 36(10):991-6. PubMed ID: 25100240
[TBL] [Abstract][Full Text] [Related]
9. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
[TBL] [Abstract][Full Text] [Related]
10. Effect of clpP and clpC deletion on persister cell number in Staphylococcus aureus.
Springer MT; Singh VK; Cheung AL; Donegan NP; Chamberlain NR
J Med Microbiol; 2016 Aug; 65(8):848-857. PubMed ID: 27375177
[TBL] [Abstract][Full Text] [Related]
11. High level of persister frequency in clinical staphylococcal isolates.
Manandhar S; Singh A; Varma A; Pandey S; Shrivastava N
BMC Microbiol; 2022 Apr; 22(1):109. PubMed ID: 35448965
[TBL] [Abstract][Full Text] [Related]
12. Combination of Antibiotics-Nisin Reduces the Formation of Persister Cell in
Narimisa N; Sadeghi Kalani B; Mohammadzadeh R; Masjedian Jazi F
Microb Drug Resist; 2021 Feb; 27(2):137-144. PubMed ID: 32429732
[TBL] [Abstract][Full Text] [Related]
13. Persister cells formation and expression of type II Toxin-Antitoxin system genes in
Amraei F; Narimisa N; Sadeghi Kalani B; Lohrasbi V; Masjedian Jazi F
Iran J Pathol; 2020; 15(2):127-133. PubMed ID: 32215028
[TBL] [Abstract][Full Text] [Related]
14. msaABCR operon is involved in persister cell formation in Staphylococcus aureus.
Sahukhal GS; Pandey S; Elasri MO
BMC Microbiol; 2017 Nov; 17(1):218. PubMed ID: 29166860
[TBL] [Abstract][Full Text] [Related]
15. Persister formation in Staphylococcus aureus is associated with ATP depletion.
Conlon BP; Rowe SE; Gandt AB; Nuxoll AS; Donegan NP; Zalis EA; Clair G; Adkins JN; Cheung AL; Lewis K
Nat Microbiol; 2016 Apr; 1():16051. PubMed ID: 27572649
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics and Functional Assessment of Toxin-Antitoxin Systems in
Habib G; Zhu Q; Sun B
Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30441856
[No Abstract] [Full Text] [Related]
17. Autoregulation and Virulence Control by the Toxin-Antitoxin System SavRS in Staphylococcus aureus.
Wen W; Liu B; Xue L; Zhu Z; Niu L; Sun B
Infect Immun; 2018 May; 86(5):. PubMed ID: 29440365
[TBL] [Abstract][Full Text] [Related]
18. Functionality and cross-regulation of the four SprG/SprF type I toxin-antitoxin systems in Staphylococcus aureus.
Riffaud C; Pinel-Marie ML; Pascreau G; Felden B
Nucleic Acids Res; 2019 Feb; 47(4):1740-1758. PubMed ID: 30551143
[TBL] [Abstract][Full Text] [Related]
19. RNA antitoxin SprF1 binds ribosomes to attenuate translation and promote persister cell formation in Staphylococcus aureus.
Pinel-Marie ML; Brielle R; Riffaud C; Germain-Amiot N; Polacek N; Felden B
Nat Microbiol; 2021 Feb; 6(2):209-220. PubMed ID: 33398097
[TBL] [Abstract][Full Text] [Related]
20. ClpP is required for proteolytic regulation of type II toxin-antitoxin systems and persister cell formation in
Tian XL; Li M; Scinocca Z; Rutherford H; Li YH
Access Microbiol; 2019; 1(8):e000054. PubMed ID: 32974554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
